Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | DUT | P33316 | 4/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8656960 | 0.82 | PKM (0.45) | CRBNPKML3MBTL1ALDH1A1LMNA | |
| SCHEMBL11581000 | 0.79 | ALDH1A1 (0.43) | CRBNPKML3MBTL1ALDH1A1LMNA | |
| SCHEMBL41240 | 0.79 | PKM (0.42) | CRBNPKML3MBTL1DUT | |
| SCHEMBL6102943 | 0.78 | CRBN (0.56) | CRBNPKML3MBTL1ALDH1A1LMNA | |
| SCHEMBL7752441 | 0.77 | PKM (0.38) | CRBNPKML3MBTL1ALDH1A1LMNA | |
| SCHEMBL9426408 | 0.77 | ALDH1A1 (0.40) | PKMALDH1A1DUT | |
| SCHEMBL1673256 | 0.77 | KMT2A (0.42) | PKML3MBTL1ALDH1A1LMNADUT | |
| SCHEMBL4278691 | 0.77 | PKM (0.38) | CRBNPKML3MBTL1ALDH1A1LMNA | |
| Glycine SCHEMBL2322499 | 0.76 | DUT (0.39) | CRBNPKMALDH1A1LMNADUT | |
| SCHEMBL2284397 | 0.76 | DBH (0.57) | ALDH1A1MTNR1AMTNR1BTP53DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390748-A | Compositions for preventing and treating influenza infection and methods of use thereof | 佐治亚大学研究基金会股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-110506119-A | The design of AAV capsid | UNIV MASSACHUSETTS | 2019-11-26 | — | — | CN | disclosed |
| CN-110456035-A | Probing analysis and its application based on cell | BERG LLC | 2019-11-15 | — | — | CN | disclosed |
| CN-110042099-A | RNA in skin and fibrotic conditions is interfered | 菲奥医药公司 | 2019-07-23 | — | — | CN | disclosed |
| CN-104822705-B | M971 Chimeric antigen receptor | 美国卫生和人力服务部 | 2019-07-12 | — | — | CN | disclosed |
| CN-106471133-B | Mononucleotide detection method | 贝斯4创新公司 | 2019-07-09 | — | — | CN | disclosed |
| CN-105378109-B | Minimizing errors using uracil-DNA-N-glycosylase | 雅培分子公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-109790211-A | Anti-KRAS-G12D T cell receptor | 美国卫生和人力服务部 | 2019-05-21 | — | — | CN | disclosed |
| CN-105131067-B | RNA in skin and fibrotic conditions is interfered | 雷克西制药公司 | 2019-02-19 | — | — | CN | disclosed |
| CN-105246507-B | VISTA Modulators for Diagnosis and Treatment of Cancer | 达特茅斯大学理事会 | 2019-01-25 | — | — | CN | disclosed |
| CN-1407900-A | Method for treating or preventing cell, tissue, and organ damage using human bone marrow progenitor cell inhibitory factor-1 (MPIF-1) | HUMAN GENOME SCIENCES INC (US) | 2003-04-02 | — | — | CN | disclosed |
| CN-1398300-A | Novel elongase gene and method for producing polyunsaturated fatty acids | BASF AG (DE) | 2003-02-19 | — | — | CN | disclosed |
| CN-1392797-A | High mannose proteins and methods of producing high mannose proteins | TRANSKARYOTIC THERAPIES INC (US) | 2003-01-22 | — | — | CN | disclosed |
| CN-1372569-A | Keratinocyte growth factor-2 | HUMAN GENOME SCIENCES INC (US) | 2002-10-02 | — | — | CN | disclosed |
| CN-1354755-A | Nucleotide and protein sequences of Nogo genes and methods based thereon | SCHWAB MARTIN E (CH) | 2002-06-19 | — | — | CN | disclosed |
| CN-1346368-A | Potassium channel interactors and uses therefor | MILLENNIUM PHARM INC (US) | 2002-04-24 | — | — | CN | disclosed |
| CN-1342208-A | Method for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides | VALIGENE CORP (US) | 2002-03-27 | — | — | CN | disclosed |
| CN-1312372-A | Intocostrin regulation area and nucleotide series determination and method used thereof | PFIZER PRODUCTS CORP (US) | 2001-09-12 | — | — | CN | disclosed |
| CN-1211255-A | Ob receptor and method of diagnosing and treating weight | MILLENNIUM PHARM INC (US) | 1999-03-17 | — | — | CN | disclosed |
| CN-1171112-A | Amino acid nucleic acids | ICN PHARMACEUTICALS CO (US) | 1998-01-21 | — | — | CN | disclosed |